Drug recall · June 2, 2021
Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36 recall
Why: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.
- Lots / codes
1139494
- Quantity
- 1669 bottles
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- FL, GA, SC
- Initiated
- March 15, 2021 · Voluntary: Firm initiated
- Classified
- May 24, 2021
- Reported
- June 2, 2021
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Creon
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.